247 related articles for article (PubMed ID: 36192728)
1. Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66-75 years in 2016-2018.
Li S; Miller-Wilson LA; Guo H; Hoover M; Fisher DA
BMC Health Serv Res; 2022 Oct; 22(1):1228. PubMed ID: 36192728
[TBL] [Abstract][Full Text] [Related]
2. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
[TBL] [Abstract][Full Text] [Related]
3. Sociodemographic Factors and Screening CT Colonography Use Among Medicare Beneficiaries.
Christensen EW; Sanelli PC; Rula EY; Chang KJ; Moreno CC; Bruining DH; Yee J
AJR Am J Roentgenol; 2024 Jan; 222(1):e2329703. PubMed ID: 37466190
[No Abstract] [Full Text] [Related]
4. The cost-effectiveness of non-invasive stool-based colorectal cancer screening offerings from age 45 for a commercial and medicare population.
Ebner D; Kisiel J; Barnieh L; Sharma R; Smith NJ; Estes C; Vahdat V; Ozbay AB; Limburg P; Fendrick AM
J Med Econ; 2023; 26(1):1219-1226. PubMed ID: 37752872
[TBL] [Abstract][Full Text] [Related]
5. Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk.
Fisher DA; Princic N; Miller-Wilson LA; Wilson K; Fendrick AM; Limburg P
JAMA Netw Open; 2021 Sep; 4(9):e2122269. PubMed ID: 34473259
[TBL] [Abstract][Full Text] [Related]
6. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
7. Adherence to colorectal cancer screening and healthcare resource utilization: a longitudinal analysis in Medicare beneficiaries aged 66-75 years.
Li S; Miller-Wilson LA; Guo H; Fisher DA
Curr Med Res Opin; 2022 Dec; 38(12):2201-2208. PubMed ID: 36205707
[TBL] [Abstract][Full Text] [Related]
8. Costs of colorectal cancer screening with colonoscopy, including post-endoscopy events, among adults with Medicaid insurance.
Fisher DA; Princic N; Miller-Wilson LA; Wilson K; Limburg P
Curr Med Res Opin; 2022 May; 38(5):793-801. PubMed ID: 35243953
[TBL] [Abstract][Full Text] [Related]
9. Quantified trends in provider reimbursement and utilization volume in colorectal cancer screenings: analysis of Medicare claims from 2000 to 2019.
Bommineni VM; Bommineni VL; Gupta R
Colorectal Dis; 2024 May; 26(5):1028-1037. PubMed ID: 38581083
[TBL] [Abstract][Full Text] [Related]
10. Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population.
Fisher DA; Karlitz JJ; Jeyakumar S; Smith N; Limburg P; Lieberman D; Fendrick AM
J Med Econ; 2021; 24(1):654-664. PubMed ID: 33902366
[TBL] [Abstract][Full Text] [Related]
11. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
[TBL] [Abstract][Full Text] [Related]
12. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
[No Abstract] [Full Text] [Related]
13. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
Ladabaum U; Mannalithara A
Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
[TBL] [Abstract][Full Text] [Related]
14. Disparities despite coverage: gaps in colorectal cancer screening among Medicare beneficiaries.
O'Malley AS; Forrest CB; Feng S; Mandelblatt J
Arch Intern Med; 2005 Oct; 165(18):2129-35. PubMed ID: 16217003
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in correlates of colorectal cancer screening among Black Medicare beneficiaries in Baltimore.
Martinez KA; Pollack CE; Phelan DF; Markakis D; Bone L; Shapiro G; Wenzel J; Howerton M; Johnson L; Garza MA; Ford JG
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1037-42. PubMed ID: 23629519
[TBL] [Abstract][Full Text] [Related]
16. Trends in colorectal cancer test use in the medicare population, 1998-2005.
Schenck AP; Peacock SC; Klabunde CN; Lapin P; Coan JF; Brown ML
Am J Prev Med; 2009 Jul; 37(1):1-7. PubMed ID: 19423273
[TBL] [Abstract][Full Text] [Related]
17. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
Berger BM; Parton MA; Levin B
Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
[TBL] [Abstract][Full Text] [Related]
18. Is the type of Medicare insurance associated with colorectal cancer screening prevalence and selection of screening strategy?
Schneider EC; Rosenthal M; Gatsonis CG; Zheng J; Epstein AM
Med Care; 2008 Sep; 46(9 Suppl 1):S84-90. PubMed ID: 18725838
[TBL] [Abstract][Full Text] [Related]
19. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare's screening reimbursement.
White A; Vernon SW; Franzini L; Du XL
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):811-7. PubMed ID: 21546366
[TBL] [Abstract][Full Text] [Related]
20. Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years.
Bian J; Bennett C; Cooper G; D'Alfonso A; Fisher D; Lipscomb J; Qian CN
J Oncol Pract; 2016 Jun; 12(6):e670-80. PubMed ID: 27189357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
